HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia.
Arza-Apalategi S, Heuts BMH, Bergevoet SM, Meering R, Gilissen D, Jansen PWTC, Krippner-Heidenreich A, Valk PJM, Vermeulen M, Heidenreich O, Haferlach T, Jansen JH, Martens JHA, van der Reijden BA.
Arza-Apalategi S, et al. Among authors: jansen pwtc.
Leukemia. 2024 Dec 4. doi: 10.1038/s41375-024-02485-3. Online ahead of print.
Leukemia. 2024.
PMID: 39633068